Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 2Phase NA 1Phase 1 1

Status

Completed 6Withdrawn 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic carcinoma, familial 1Pancreatic Intraductal Neoplasms 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 25Blood Specimen Collection 20Radiotherapy 19Surveys and Questionnaires 18Exercise 17Early Intervention, Educational 17Methods 16Standard of Care 15Cyclophosphamide 15Surgical Procedures, Operative 14Radiotherapy, Intensity-Modulated 14Biopsy 13Acupuncture Therapy 12Interviews as Topic 11Educational Status 11Cisplatin 11Filgrastim 10Radiofrequency Ablation 9Magnetic Resonance Imaging 9Fluorodeoxyglucose F18 9fludarabine phosphate 8Radiation 8Practice Guidelines as Topic 8Gemcitabine 8X-Rays 7Sorafenib 7Granulocyte Colony-Stimulating Factor 7Colonoscopy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Terminated × Ferrosoferric Oxide × Clear all
NCT02070705 2025-07-31

DCE MRI in Patients With Pancreatic Cancer

OHSU Knight Cancer Institute

Phase NA Terminated
77 enrolled
Gastrointestinal

Pancreatic carcinoma, familial, Pancreatic Intraductal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡